Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

HKG:8329 Revenue

Shenzhen Neptunus Interlong Bio-technique Company had revenue of 436.17M CNY in the half year ending June 30, 2026, a decrease of -19.90%. This brings the company's revenue in the last twelve months to 912.25M, down -8.14% year-over-year. In the year 2025, Shenzhen Neptunus Interlong Bio-technique Company had annual revenue of 972.01M, down -6.69%.

• Revenue (ttm): 912.25M CNY
• Revenue Growth: -8.14%
• P/S Ratio: 0.16
• Revenue / Employee: 690.58K CNY
• Employees: 1,321
• Market Cap: 167.80M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	972.01M	-69.69M	-6.69%
Dec 31, 2024	1.04B	-23.16M	-2.18%
Dec 31, 2023	1.06B	78.17M	7.92%
Dec 31, 2022	986.69M	147.89M	17.63%
Dec 31, 2021	838.81M	-192.56M	-18.67%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error